Bringing the fundamentals into focus…
Back to Atara Biotherapeutics, Inc.
How Atara Biotherapeutics, Inc. stacks up
ATRA · against 85 other Healthcare companies of similar size
Profitability
29/ 100
Above the middle of the pack.
Ranked #42 of 86 · scores higher than 52% of peers
Bars: peers in each 10-point band of the profitability score12 peers with a profitability score of 20–29, including ATRA · Click a bar to see the companies
Why profitability scores 29?
Weighted metrics compared with all Healthcare companies.Mainly because of its return on assets, which is weaker than most Healthcare peers.
- a lower return on assets: weaker than 83% of peers. Return on assets: -24.1% vs peer median 1.7%
- Return on invested capital is not reported, so it is left out of the score.
- a wider operating margin: stronger than 92% of peers. Operating margin: 29.7% vs peer median 7.1%
Metric by metric
Position: dot = ATRA, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | ATRA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 57 reported | Not reported | -8.9% | — | — | 33% |
| Operating marginHigher is better · 81 reported | 29.7% | -7.4% | 96% | 33% | |
| Return on assetsHigher is better · 91 reported | -24.1% | -6.1% | 24% | 33% | |
| Return on equityHigher is better · 81 reported | Not reported | -11.8% | — | — | Context only |
| Gross marginHigher is better · 93 reported | 75.3% | 42.2% | 80% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by profitability score
Top 5 and the companies ranked around ATRA| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 592M ILS (≈$160M) | 96 | 84 | |
| 2 | 157M USD | 95 | ||
| 3 | 144.4B KRW (≈$104M) | 88 | 56 | |
| 4 | 376M BRL (≈$68M) | 81 | 56 | |
| 5 | 1.1B HKD (≈$146M) | 80 | 72 | |
| 38 | 2.9B TWD (≈$90M) | 33 | 58 | |
| 38 | 131M CAD (≈$96M) | 33 | 40 | |
| 38 | 60M USD | 33 | 33 | |
| 41 | 51M EUR (≈$56M) | 31 | 22 | |
| 42 | 82M USD | 29 | 27 | |
| 43 | 172.4B KRW (≈$124M) | 28 | 26 | |
| 44 | 580M HKD (≈$74M) | 27 | 7 | |
| 44 | 83.8B KRW (≈$60M) | 27 | 54 | |
| 46 | 64.3B KRW (≈$46M) | 25 | 24 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score